They claim to increase metabolism by raising the fat-burning mechanism, thereby contributing to weight reduction 12 , 14
GLP-1 Drugs for Obesity: How to Switch From the Needle to a Pill Now that two oral glucagon-like peptide-1 (GLP-1) receptor agonist medications are approved by the U.S
If successful across all indications, retatrutide could receive approval for weight management , type 2 diabetes, cardiovascular risk reduction, knee osteoarthritis, and liver disease
It works by reducing appetite, slowing digestion, increasing calorie burn, and improving insulin sensitivity, creating a comprehensive metabolic shift that supports sustained fat loss
Get exclusive access to fashion and beauty trends, hot-off-the-press celebrity news, and more
Clinical data shows that appetite-suppressing benefits typically diminish within 46 weeks of your last dose